Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

BUY
$13.31 - $19.86 $142,417 - $212,502
10,700 New
10,700 $212,000
Q2 2021

Aug 11, 2021

SELL
$34.41 - $44.03 $980,684 - $1.25 Million
-28,500 Reduced 57.58%
21,000 $896,000
Q1 2021

May 17, 2021

BUY
$37.29 - $47.19 $697,323 - $882,453
18,700 Added 60.71%
49,500 $1.9 Million
Q4 2020

Feb 16, 2021

SELL
$34.3 - $44.09 $583,100 - $749,530
-17,000 Reduced 35.56%
30,800 $1.35 Million
Q3 2020

Nov 16, 2020

BUY
$27.86 - $39.35 $465,262 - $657,145
16,700 Added 53.7%
47,800 $1.88 Million
Q2 2020

Aug 14, 2020

BUY
$30.3 - $42.55 $103,020 - $144,670
3,400 Added 12.27%
31,100 $981,000
Q1 2020

May 15, 2020

BUY
$30.0 - $54.18 $381,000 - $688,086
12,700 Added 84.67%
27,700 $975,000
Q4 2019

Feb 14, 2020

BUY
$42.29 - $52.2 $190,305 - $234,900
4,500 Added 42.86%
15,000 $729,000
Q3 2019

Nov 14, 2019

BUY
$42.06 - $51.64 $42,060 - $51,640
1,000 Added 10.53%
10,500 $499,000
Q2 2019

Aug 14, 2019

SELL
$33.93 - $43.66 $203,580 - $261,959
-6,000 Reduced 38.71%
9,500 $408,000
Q1 2019

May 15, 2019

BUY
$26.74 - $41.32 $136,374 - $210,732
5,100 Added 49.04%
15,500 $599,000
Q3 2018

Nov 14, 2018

SELL
$33.27 - $39.25 $146,388 - $172,700
-4,400 Reduced 29.73%
10,400 $407,000
Q2 2018

Aug 14, 2018

BUY
$21.73 - $33.15 $321,604 - $490,620
14,800 New
14,800 $479,000
Q1 2018

May 15, 2018

SELL
$21.05 - $26.6 $635,710 - $803,320
-30,200 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$23.37 - $29.26 $422,997 - $529,606
18,100 Added 149.59%
30,200 $715,000
Q3 2017

Nov 14, 2017

BUY
$27.25 - $31.55 $329,725 - $381,755
12,100
12,100 $341,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.